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Abstract
The da Vinci Surgical System is an innovative technology that has advanced the lapa-
roscopic treatment of benign and malignant diseases in gynecology. In this chapter, we 
will discuss the da Vinci Surgical System technology, including its history, utilization, 
surgical technique for benign and oncologic hysterectomy, future directions and surgical 
complications. Through a review of the literature, we aim to chronicle the current trends 
of application in both benign and oncologic gynecologic conditions and describe the cur-
rent standards of care in this innovative and evolving operative technology. Although 
the future utility of robotic surgeries and robotic hysterectomies necessitates further 
research, the potential application of this surgical method affords great promise.
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1. History
The initial da Vinci robotic surgical system (Intuitive Surgical, Sunnyvale, CA) was released in 
Europe in 1999 and received FDA approval in 2000 [1]. In 2005, the FDA approved the da Vinci 
robotic system for gynecological surgeries. The first system consisted of two robotic operating 
arms and one camera holder. Since its emergence in the surgical arena, there have been four 
updates to the system, each of which has increased its overall capability within various surgical 
subspecialties and overall maneuverability of instrument use. The latest version termed the da 
Vinci Xi was released in 2014 and includes 3D HD vision, four quadrant mounting, and instru-
ments capable of moving in seven degrees of motion while performing complex surgical tech-
niques including clamping, cutting, coagulating, dissecting, suturing and manipulating tissue [2].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
In 2002, Diaz-Arrastia et al. published a series of 11 patients undergoing uncomplicated da 
Vinci assisted total laparoscopic hysterectomy and bilateral salpingo-oophorectomy demon-
strating feasibility for its use in gynecologic surgery [3]. Subsequently, Lambaudie et al. pub-
lished a report of 28 patients undergoing various da Vinci assisted surgical procedures for 
gynecologic cancer including total hysterectomy, bilateral oophorectomy, and pelvic and/or 
para-aortic lymphadenectomy. The authors found that the use of robot-assisted laparoscopy 
led to less intraoperative blood loss, less postoperative pain and shorter hospital stays com-
pared with those treated with more traditional surgical approaches such as laparoscopy and 
laparotomy [4]. The following year the FDA approved the use of the da Vinci robotic system 
for use in gynecologic oncology surgery.
2. Introduction
Over the past 12 years, the da Vinci assisted approach to laparoscopic hysterectomy has taken 
a more prominent role in the surgical management of a multitude of benign and oncologic 
gynecologic conditions. Multiple meta-analyses and literature reviews have shown that the 
use of robotic surgery offers the advantage of decreased blood loss and length of stay when 
compared to open surgical techniques [5]. When compared to traditional laparoscopic meth-
ods outcomes appear to be equivocal, but a case can be made for the advantages of robotic 
surgery to treat obese patients [6]. The main disadvantages of robotic gynecologic surgery 
include increased intraoperative time and cost-effectiveness questionability. Such issues may 
be mitigated as operator proficiency increases. Future projections of advancement in robotic 
gynecologic surgery highlight the use of minimal incisions and single site approaches [7].
Hysterectomy is one of the most frequently performed surgical procedures in the United 
States. Common benign indications include symptomatic uterine leiomyomas (51.4%), abnor-
mal uterine bleeding (41.7%), endometriosis (30%), and prolapse (18.2%) [8, 9].
The American College of Obstetricians and Gynecologists favors vaginal hysterectomy as the 
preferred method among women undergoing hysterectomy for benign disease [10]. A 2015 
Cochrane Database Systematic Review indicated that vaginal hysterectomy appears to be 
superior to both laparoscopic hysterectomy and abdominal hysterectomy as it is associated 
with faster return to normal activities [11]. However, in cases involving factors such as adnexal 
pathology, severe endometriosis, adhesions, or an enlarged uterus, vaginal hysterectomy 
may not be appropriate [10]. Compared to abdominal hysterectomy, laparoscopic hysterec-
tomy is associated with decreased risk of perioperative complications, faster return to normal 
activity, decreased length of hospital stay, decreased risk of readmission, decreased risk of 
surgical site infection, decreased blood loss and need for blood transfusion, and improved 
postoperative quality of life [11]. Though current evidence demonstrates a less significant 
difference between robot-assisted laparoscopic hysterectomy and conventional laparoscopic 
hysterectomy, potential benefits of the robotic-assisted approach include decreased complica-
tion rate, decreased length of hospital stay, decreased blood loss and need for blood transfu-
sion, and decreased risk of conversion to exploratory laparotomy for surgically complicated 
cases and obese patients [9, 12–19]. With an increasing number of both academic institutions 
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and community hospitals offering robotic surgery, there is a national uptrend in rates of the 
robotic-assisted approach. Of all benign hysterectomies, robotic-assisted surgery increased 
from 0.5% in 2007 to 9.5% in 2010 [9, 13, 18, 20–27].
In the context of gynecologic oncology, common indications for hysterectomy include can-
cers of the endometrium, cervix, ovary or fallopian tube. The 2017 NCCN Clinical Practice 
Guidelines in Oncology for Uterine Neoplasm state that “Minimally invasive hysterectomy is 
now the preferred approach when technically feasible” [28]. The randomized controlled trial 
LAP2 showed short-term surgical benefits of laparoscopy over laparotomy for uterine cancer 
staging, and follow-up data showed equivalent oncologic outcomes [29]. In the case of cervi-
cal cancer, even though we do not have phase III data supporting the use of minimally inva-
sive surgery, there is a body of literature demonstrating feasibility and suggesting equivalent 
oncologic outcomes compared to abdominal hysterectomy [30–32].
Robotic surgery has taken center stage in becoming the standard of care in patients with 
early-stage endometrial and cervical cancer. When comparing robotic-assisted surgery with 
conventional laparoscopy for endometrial cancer, robotic surgery has been found to have 
decreased length of stay, reduced operating time, decreased blood loss, and more rapid post-
surgical recovery [6]. Furthermore, robotic surgery has even been shown to result in high 
lymph note count as compared to conventional laparoscopy when performed in obese women 
with endometrial cancer [33]. In comparing robot-assisted surgery with abdominal surgery for 
endometrial cancer, robotic surgery is associated with decreased blood loss, reduced length 
of stay, increased operation duration, and equal number of lymph node counts [20, 34–40]. In 
analyzing total cost of care for endometrial cancer patients, robotic surgery has been shown 
to be significantly cheaper ($8212.00 versus $12,943.60, P = .001) due to its association with a 
decreased length of stay [20, 34, 41]. In patients with early cervical cancer, robotic-assisted 
and conventional laparoscopic radical hysterectomy have both been shown to be superior to 
exploratory laparotomy due to decreased blood loss, decreased complication rates, reduced 
the length of stay, and increased lymph node count. In such patients, there is conflicting data 
showing the advantage of the robotic approach over conventional laparoscopy [36, 42–58]. 
There is currently limited data on the use of robotics in the setting of advanced ovarian cancer, 
and thus its use is not recommended at this time [3, 4, 59–63].
In this chapter, we will describe the technology behind the robotic-assisted surgery, patient 
preparation, surgical technique for simple and radical hysterectomy and complications.
3. The technology
Robot-assisted laparoscopy is an innovative advancement in gynecologic laparoscopic surgery. 
The robotic approach enhances traditional laparoscopy by providing three-dimensional optics, 
advanced ergonomics, improved vision and precision, tremor filtration, and 7° of motion with 
advanced dexterity [2]. There are currently four generations of the da Vinci Surgical System: 
The “standard”, the S, the Si, the X and the Xi system. The components of the da Vinci Surgical 
System include the surgeon console, the patient side cart, and the vision system [2] (Figure 1).
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The surgeon operates seated at the console while viewing a 3D high-definition image inside 
the patient’s body. The surgeon’s fingers grasp the master controls below the display which 
converts the surgeon’s hand, wrist and finger movements into precise, simultaneous move-
ments of surgical instruments [2].
The patient-side cart is where the patient is positioned during surgery. Attached to the side 
cart are four robotic arms that facilitate the surgeon’s commands by moving around fixed 
pivot points which allow for less force on the abdominal wall than laparoscopy [2]. The vision 
system is equipped with a 3D, high-definition endoscope and image processing equipment 
for visualization of the patient’s anatomy [2]. A view of the operating field is available to the 
entire OR team on a large viewing monitor (vision cart) [2].
A full range of EndoWrist instruments (Intuitive Surgical, Sunnyvale, CA) is available to the 
surgeon while operating. Most instruments are modeled after the human wrist, offering a 
greater range of motion than the human hand. Each instrument is designed for a particular 
task, such as clamping, cutting, coagulating, dissecting, suturing and manipulating tissue. 
EndoWrist Instruments feature 7° of freedom, 90° of articulation, natural motion and finger-
tip control, motion scaling and tremor reduction [2]. Energy instruments include da Vinci 
monopolar and bipolar cautery instruments (electrical energy), the da Vinci Harmonic™ 
ACE (mechanical energy), the da Vinci PK™ Dissecting Forceps (advanced bipolar), and 
laser [2]. Grasping instruments allow handling thin, delicate tissues as well as thicker and 
stronger tissues. Needle drivers provide the ability to suture with fine and thick needles. 
SutureCut™ Needle Drivers include a cutting blade for efficient cutting of suture after knot 
tying [2].
4. Indications
Robotic hysterectomy may be employed for a wide spectrum of benign pathologies including 
leiomyoma, abnormal uterine bleeding, endometriosis, adenomyosis, adnexal mass, pelvic 
Figure 1. (a) Surgeons console; (b) patients side-cart; and (c) vision tower.
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pain, and pelvic organ prolapse. Common malignant pathologies necessitating hysterectomy 
include primary cancers of the uterus, ovary, cervix, fallopian tubes, and peritoneum; as well 
as nongynecologic metastases of urologic, colorectal, breast, gastrointestinal, renal, pulmo-
nary, melanomatous, or lymphatic origin.
5. Technique
After induction of general endotracheal anesthesia and insertion of an orogastric tube, the 
patient is placed in dorsal lithotomy position using yellowfin stirrups with careful padding 
of pressure points. Both arms are padded and tucked to the sides. The patient is placed in 
steep Trendelenburg position (27–30°) to allow mobilization of the small bowel out the pel-
vic area and exposing the aorta if in need to perform lymph node dissection. She is prepped 
and draped in the standard sterile fashion. Foley catheter is inserted, and a uterine manipu-
lator such as a V-care manipulator (ConMed Endosurgery, Utica, NY) or the Advincula 
Arch uterine manipulator (Cooper Surgical, Trumbull, CT) is placed. The uterine manipula-
tor allows demarcation of the cervicovaginal junction necessary to perform the colpotomy.
5.1. Port placement
Port placement can differ based on uterine size, the need to do lymph node dissection, using 2 
or 3 operative arms and the da Vinci system used (Figure 2). The endoscope port is the refer-
ence port for all other ports. If not doing lymph node dissection and with a small uterus, the 
camera port can be placed 8–10 cm above the fundus which ends up being at the umbilicus. 
For oncologic surgery, we place the camera port 20–25 cm above the pubic bone [64]. When 
using the S or Si system we place a 10–12 mm laparoscopic port for the camera and when 
using the Xi system we place the 8 mm da Vinci camera trocar. The ports need to be 6–10 cm 
apart to allow triangulation and avoid arms collision. When using three operative arms, the 
surgeon can decide to place the third arm either at the right or left hemi-abdomen. Placing the 
third operative arm on the right will result in controlling both arms with the surgeon’s right 
hand and vice versa if placed on the left hemi-abdomen.
When using the Xi system the operative ports can be placed in a straight line at the level of the 
umbilicus but all ports can be shifted up for a large uterus or for lymph node dissection. The 
assist port is usually placed 2–3 cm under the left rib cage over the mid-clavicular line (Palmer 
point) but can be place in the lower quadrants. Careful placement should be done to avoid plac-
ing the assistant port in a straight line with the target anatomy and an operative port. This would 
result in difficult access to the surgical field for the assistant. We like using either a 5 or 8 mm 
Airseal trocar for the assist port (ConMed Utica, NY). When using the S or Si systems operative 
ports should be placed 8–10 cm apart and keeping 10–20 cm distance to the target anatomy.
5.2. Docking the patient-side cart
For gynecologic surgery, docking can be done either between the patient’s legs or from the side 
(Figure 3). We like side docking because it allows for an assistant to occupy the space between 
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Figure 3. Side docking. Side docking with the Xi and S system.
the legs and use the uterine manipulator and deliver specimens through the vagina with-
out difficulty. When using the S system, the robotic column is positioned at a 45° acute angle 
relative to the cephalad/caudal axis of the patient. When using the Xi system the patient-side 
Figure 2. (a) Port placement for the Xi system showing 3 operative arms and 2 operative arms configuration and (b) port 
placement for the S and Si systems.
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cart can be approached in almost any angle to the bed and the arms are rotated to fix their 
position.
5.3. Simple hysterectomy technique
A survey of the entire abdominal cavity is performed laparoscopically. Once the robotic col-
umn is successfully docked bipolar forceps are inserted into the left-sided instrument port, 
monopolar scissors are inserted into the right-sided instrument port, and a grasper inserted 
into the rightmost port. The assistant seated at the left upper quadrant assistant port starts the 
procedure with a suction irrigator, laparoscopic bowel grasper, laparoscopic Maryland, and 
laparoscopic scissors all on hand.
The pelvic peritoneum is incised parallel to the infundibulopelvic ligament. The external iliac 
artery is identified and traced down to the bifurcation of the common iliac artery. The ureter is 
found entering the pelvis at the level of the bifurcation. At this point, the ovarian vessels con-
tained in the infundibulopelvic ligament are isolated from the ureter by creating a window in 
the posterior sheet of the broad ligament. Either the ovarian vessels are clamped, cauterized and 
transected if a salpingo-oophorectomy is intended or the utero-ovarian ligament. The posterior 
sheet of the broad ligament is extended in the direction of the uterosacral ligament skeleton-
izing the uterine artery. The round ligament is then clamped, cauterized and transected. The 
anterior sheet of the broad ligament is opened in the direction of the vesicouterine perito-
neal reflexion. After performing this procedure bilaterally, the bladder is mobilized off of 
the upper vagina to expose the cervicovaginal junction marked by the colpotomizer of the 
uterine manipulator. The uterine vessels are then clamped, cauterized and transected at a 90° 
angle at the cervico-uterine junction. The cardinal ligament is then clamped, cauterized and 
transected medially to the uterine vessel pedicle and parallel to the cervix. After performing 
the colpotomy, the specimen is delivered through the vagina. A sterile glove filled with a lap 
sponge is inserted into the vagina once the specimen is successfully extracted to maintain 
adequate pneumoperitoneum. The vaginal cuff is then closed using either one polysorb or 
v-lock suture.
5.4. Radical hysterectomy
The surgical technique is similar to the traditional Type III abdominal radical hysterectomy. The 
avascular spaces (pararectal, paravesical and obturator spaces) are developed to identify the ure-
ters, the major vessels (external and interior iliac arteries, the superior vesical and uterine arter-
ies), the obturator nerve and the genitofemoral nerve (Figure 4). The uterine artery is cauterized 
and transected at its origin and mobilized medially to expose the ureter. Complete ureterolysis 
is performed to the canal of Wertheim, and the ureter is then unroofed allowing to mobilize both 
the ureter and the bladder away from the upper third of the vagina. The peritoneum between 
both uterosacral ligaments is incised, and the paravesical space is bluntly developed, thus allow-
ing transection of the uterosacral ligament at its origin. The paracolpos is then clamped, cauter-
ized and transected parallel to the vagina allowing to perform the upper vaginectomy.
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6. Future robotic surgery
6.1. Multiport and single port
Single port laparoscopy is a relatively new advancement in minimally invasive surgery. Da Vinci 
surgery with Single-Site has been approved for cholecystectomy, hysterectomy, and salpingo-
oophorectomy in benign conditions. Traditional or robotic-assisted single port laparoscopy for 
hysterectomy and other gynecologic procedures such as myomectomy and adnexal surgery 
has been reported in the literature with favorable outcomes [65–67]. Known advantages include 
improved cosmetic appearance as there is only one incision, decrease postoperative pain and 
wound infection, and minimization of potential damage to vasculature during port placement 
[68, 69]. However, single port laparoscopy has technical difficulties including instrument crowd-
ing leading to increased collision between instruments and limited degree of movement. There is 
also an increased risk of an incision-site hernia with single-port surgery. The da Vinci with Single-
site technology for a hysterectomy requires a multichannel access port with an insufflation valve 
and space for four cannulas. Two curved ports are for the robotic controlled instruments, one port 
holds the endoscope, and the final one is the designated assistant port. In the current literature, 
there are only retrospective study designs that compare single port laparoscopy with multiport 
while using the da Vinci robotic system. Paek et al. compared surgical outcomes of single robotic 
site (n = 25) and laparoendoscopic single-site total hysterectomy (n = 442) for benign disease states 
[70]. The study found that the robotic group had a lower complication rate, and less operative 
bleeding, however, there was significantly longer operating times when compared to the laparo-
scopic group. Lopez et al. also found an increase in total operative time (approximately 25 min) 
while using the robotic-assisted single site compared to laparoscopic single site [71]. In this study, 
there was a significant decrease in length of hospital stay by 8 h in the robotic arm. Gungor et al. 
compared the operative time, perioperative and early operative complication rate, conversion to 
another technique rate, postoperative pain, and recovery time, and found that there were no sig-
nificant differences between single site laparoscopy vs. robotic hysterectomy for benign disease 
[72]. Single site robotic and laparoscopic surgery was deemed to be safe and feasible techniques for 
Figure 4. Right retroperitoneal pelvic sidewall anatomy. 
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total hysterectomy. In the hands of an experienced robotic surgeon, the learning curve of robotic 
laparoendoscopic single site surgery is fast, requiring 13 cases significantly decrease operative 
time [73]. While single port robotic-assisted hysterectomy seems promising, a Cochrane review 
reports that there is a lack of evidence of any benefit of a single port or robot-assisted hysterectomy 
when compared to traditional multi-port laparoscopic hysterectomy [11]. Future randomized con-
trol trials are needed to evaluate the potential advantages of robotic single site surgery.
7. Surgical complications
New causes of complication have been introduced with robotic-assisted surgery, but the over-
all incidence of complications is similar to those of conventional laparoscopic surgery. The 
FDA database reports 21% of injuries attributed to operator-related error and 14% to techni-
cal system failure [74]. The main drawback from robotic-assisted surgery is the loss of tactile 
feedback that can result in complications from poor tissue handling, blunt dissection of dense 
adhesions or inappropriate tying of sutures [75]. Other causes of complications in robotic-
assisted surgery are note keeping the instruments in view, defects in protective sheaths of the 
shears, collision of instruments, poor positioning of the patient, port and trocar placement, 
vaginal vault dehiscence and cuff infection, and lack of communication within the team.
Steep Trendelenburg is often required to expose the pelvic anatomy and the para-aortic area 
during oncologic surgery. Prolonged Trendelenburg can result in mild head contusion, sub-
cutaneous ecchymosis, orbital pain and peri-orbital edema, corneal abrasion, visual loss, 
laryngeal edema, nerve injuries. Reducing operative time or reversing Trendelenburg after 
4–5 h, restrictive fluid replacement, adequate padding at pressure points can prevent some of 
these complications [75].
Specific organ injuries during robotic-assisted surgery have a similar incidence than during 
laparoscopic surgery. A systematic review of the literature comparing robotic surgery to lapa-
rotomy and conventional laparoscopy for cervical cancer shows comparable risk of urologic 
injuries (less than 1% bladder injuries and less than 3% ureteric injuries) [76]. Urologic inju-
ries can be prevented by thoroughly identifying the ureter and careful surgical technique 
avoiding excessive devascularization of the ureter and excessive use of the cautery. The use 
of prophylactic stents in conventional laparoscopy and laparotomy has not shown to be cost 
effective for the prevention of urologic injury and has not been studied in robotic-assisted 
gynecologic surgery [77, 78]. Bowel and vascular injuries have a low incidence and similar 
causes than conventional laparoscopic surgery. Some preventive measures can be used to 
reduce injury during entrance to the abdominal cavity but no specific technique (veress nee-
dle, open technique) has shown to be superior to prevent injuries. Good surgical technique 
with good exposure and correct use of electric energy are important to prevent injuries. The 
majority of bowel injuries are recognized intra-operatively (87%) and repaired by minimally 
invasive approach (58%) [79]. Nerve injuries can occur due to poor patient positioning but also 
during lymph node dissection (genitofemoral nerve, obturator nerve) and parametrial dis-
section (para-sympathetic plexus) during radical hysterectomy. Although vaginal cuff dehis-
cence is uncommon, it is more prevalent in robotic surgery than conventional laparoscopy, 
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laparotomy and vaginal surgery. It is reported in up to 1.5% of hysterectomies done for benign 
disease and up to 2.5% for oncologic disease [80, 81]. Several measures are recommended to 
limit the incidence of vaginal cuff dehiscence like the use of cutting mode electrocautery dur-
ing the colpotomy to reduce thermal injury, incorporating 5 mm of healthy tissue from the 
vaginal edge, incorporating the posterior peritoneum and uterosacral ligaments for better 
support and avoiding vaginal trauma (intercourse, tampons, Valsalva) for 6–12 weeks [75]. 
In a review of the United States Food and Drug Administration (FDA) Manufacture and User 
Device Experience (MAUDE) Database reporting of gynecologic robotic procedures (the 
majority of which consisted of robotic hysterectomy) for the year 2012, risk of major operative 
injury was 0.08% and the risk of death was 0.007% [82].
8. Information for patients
Patients should be provided instructions regarding perioperative information and expectations. 
Patients should remain NPO starting at the 12 am hour before surgery. Bowel preparation is 
not necessary unless bowel resection is anticipated. Prior to proceeding to the operating room 
patients will review and sign procedure consents with their surgeon. Detailed information 
regarding possible intraoperative complications is detailed above in Section 7. In general patients 
should be made aware that risks of robotic assisted laparoscopic hysterectomy include but not 
be limited to vascular injury, hemorrhage, infection, injury to bowel, bladder, ureters, nerves, 
and other structures adjacent to the operative field. Patients should be informed that the risk of 
major morbidity and death are both small (approximately <1% and <0.01% respectively) [82]. 
In some cases reoperation with additional surgical interventions such as bowel resection with 
reanastamosis and/or diversion and ureteral reimplantation may be necessary. Major causes of 
postoperative morbidity include sepsis and venous thromboembolism. Prophylactic antibiot-
ics and pharmacologic anticoagulation are often administered to minimize these risks. The 
majority of patients undergoing robotic hysterectomy are discharged home within 24–48 h of 
surgery, with a large portion of patients going home on the same day as surgery.
9. Conclusion
The da Vinci Surgical System is an innovative technology that has advanced the laparo-
scopic treatment of benign and malignant diseases in gynecology. Da Vinci assisted laparo-
scopic hysterectomy has advantages over open, traditional laparoscopic, and even vaginal 
approaches in some cases. This surgical technique is proliferating and being adopted by 
university and community hospitals across the country. As the literature on the benefits 
of da Vinci assisted hysterectomy continues to grow, so does operator proficiency and its 
use in operating rooms. The newer da Vinci models have increased movement efficiency 
and visual capacity. Although the future utility of robotic surgeries and robotic hysterecto-
mies necessitates further research, the potential application of this surgical method affords 
great promise.
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